The Impact of Benign Prostatic Hyperplasia Surgery on Patients’ Quality of Life

Abstract

Objective: To assess the impact of surgical treatment of benign hyperplasia of the prostate on patients’ quality of life (QoL). Material and Methods: The QoL of 181 patients was assessed by the health questionnaire SF-36. The measurement was carried out before and 6 months after surgery. Results: After surgery, SF-36 scales improved their scores, fundamentally General Health (57.4%) and Physical Functioning (57.1%). 70.3% improved their physical component summary (PCS) and 49.1% their mental component summary (MCS). The improved PCS and MCS were not associated with the improved I-PSS or urine flow. The improved PCS was 2.2 times higher in patients who had previously scored under 44 in the PCS, 2.2 in patients who had scored over 25 in the I-PSS, and 2.9 times higher in patients without chronic diseases. With regard to MCS improvement, this was 17.1 times higher in patients who scored under 50 previously on the MCS, 3.1 in patients who scored over 4 on the IQL, 5.7 in patients without postoperative incontinence, and 3.3 times higher in patients who lived in urban areas. Conclusions: Improvement in QoL after surgery is noted more in physical than in psychological aspects. Although a reduction in the intensity of prostatic symptoms and an increase in urine flow values were noted postoperatively, the improvement QoL was not associated with improved symptoms or urinary flow.

Preoperative urodynamic and symptom evaluation of patients undergoing transurethral prostatectomy: analysis of variables relevant for outcome

“…However, a rate of short‐term symptomatic failure after TURP of 15–20% is not uncommon and not generally related to preoperative urodynamic findings [10,11]. Moreover, it has been reported that the improvement in quality of life after surgery for BPE, as assessed by measurements of general health and physical functioning, is not related to improvements in symptom scores or Q max [12]. Thus, while the pathophysiological significance of BOO in patients with LUTS is undisputed, it is not as clear that urodynamically confirmed BOO should be the basis for TURP.…”

El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos

“…En la muestra de pacientes con hiperplasia prostática benigna que requirieron cirugía 38 , las puntuaciones obtenidas 1 año después de la operación mostraron una mejora significativa en todas las escalas del cuestionario. Las magnitudes del efecto fueron mayores de 0,5, lo que denota un cambio moderado, para la escala de Rol físico y para la PCS.…”

“…La versión española del SF-36 es uno de los instrumentos genéricos más utilizados en el territorio nacional, tanto en estudios descriptivos que miden el impacto sobre la CVRS en distintas poblaciones de pacientes 33,41,53-83 como para la evaluación de intervenciones terapéuticas [35][36][37][38][83][84][85][86][87][88][89][90][91][92][93][94] . También se ha utilizado como referencia en la validación de nuevos instrumentos de medición 56,[95][96][97][98][99][100][101][102][103] .…”